Novartis launches “not-for-profit” COVID-19 portfolio

20 July 2020 - Deborah Wilkes

Archived

Novartis has launched a “not-for-profit” portfolio of generic and OTC medicines for symptomatic treatment of COVID-19.

Click tags below for more information on topics:

Novartis Sandoz COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: